Search filters

List of works by Christine E Hallgreen

A comprehensive approach to benefit-risk assessment in drug development.

scientific article

Allometric relationship between changes of visceral fat and total fat mass

scientific article published on 18 December 2007

Are monitoring instructions provided in direct healthcare professional communications (DHPCs) of sufficient quality? A retrospective analysis of DHPCs sent out between 2007 and 2018

scientific article published on 11 May 2020

Balancing benefit and risk of medicines: a systematic review and classification of available methodologies

scientific article published on 13 May 2014

Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology.

scientific article published on 5 July 2014

Differences and similarities in medicine use, perceptions and sharing among adolescents in two different educational settings

scientific article published on 23 November 2017

How and Why to Involve Patients in Drug Development: Perspectives From the Pharmaceutical Industry, Regulatory Authorities, and Patient Organizations

scientific article published on 07 August 2019

How and Why to Involve Patients in Drug Development: Perspectives From the Pharmaceutical Industry, Regulatory Authorities, and Patient Organizations

scientific article published on 06 January 2020

Literature review of visual representation of the results of benefit-risk assessments of medicinal products

scientific article

Recommendations for benefit-risk assessment methodologies and visual representations

scientific article

Serious adverse events reported for antiobesity medicines: postmarketing experiences from the EU adverse event reporting system EudraVigilance.

scientific article published on August 2016

Paulina is supported by:

About Paulina

Help